APA
Charles P., Terrier B., Perrodeau É., Cohen P., Faguer S., Huart A., Hamidou M., Agard C., Bonnotte B., Samson M., Karras A., Jourde-Chiche N., Lifermann F., Gobert P., Hanrotel-Saliou C., Godmer P., Martin-Silva N., Pugnet G., Matignon M., Aumaitre O., Viallard J., Maurier F., Meaux-Ruault N., Rivière S., Sibilia J., Puéchal X., Ravaud P., Mouthon L. & Guillevin L. (20190805). Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2). : Annals of the rheumatic diseases.
Chicago
Charles Pierre, Terrier Benjamin, Perrodeau Élodie, Cohen Pascal, Faguer Stanislas, Huart Antoine, Hamidou Mohamed, Agard Christian, Bonnotte Bernard, Samson Maxime, Karras Alexandre, Jourde-Chiche Noémie, Lifermann François, Gobert Pierre, Hanrotel-Saliou Catherine, Godmer Pascal, Martin-Silva Nicolas, Pugnet Grégory, Matignon Marie, Aumaitre Olivier, Viallard Jean-François, Maurier François, Meaux-Ruault Nadine, Rivière Sophie, Sibilia Jean, Puéchal Xavier, Ravaud Philippe, Mouthon Luc and Guillevin Loïc. 20190805. Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2). : Annals of the rheumatic diseases.
Harvard
Charles P., Terrier B., Perrodeau É., Cohen P., Faguer S., Huart A., Hamidou M., Agard C., Bonnotte B., Samson M., Karras A., Jourde-Chiche N., Lifermann F., Gobert P., Hanrotel-Saliou C., Godmer P., Martin-Silva N., Pugnet G., Matignon M., Aumaitre O., Viallard J., Maurier F., Meaux-Ruault N., Rivière S., Sibilia J., Puéchal X., Ravaud P., Mouthon L. and Guillevin L. (20190805). Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2). : Annals of the rheumatic diseases.
MLA
Charles Pierre, Terrier Benjamin, Perrodeau Élodie, Cohen Pascal, Faguer Stanislas, Huart Antoine, Hamidou Mohamed, Agard Christian, Bonnotte Bernard, Samson Maxime, Karras Alexandre, Jourde-Chiche Noémie, Lifermann François, Gobert Pierre, Hanrotel-Saliou Catherine, Godmer Pascal, Martin-Silva Nicolas, Pugnet Grégory, Matignon Marie, Aumaitre Olivier, Viallard Jean-François, Maurier François, Meaux-Ruault Nadine, Rivière Sophie, Sibilia Jean, Puéchal Xavier, Ravaud Philippe, Mouthon Luc and Guillevin Loïc. Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2). : Annals of the rheumatic diseases. 20190805.